To investigate the pathogenesis of acute Mycoplasma pneumoniae infection, BALB/c mice were anesthetized with metofane, and M. pneumoniae was introduced intranasally on days 0, 1, and 2. Mice were sacrificed on days 0-15. A histopathologic scoring system defined inflammatory changes in the lungs on a scale of 0-26 (least to most severe). Broth cultures were positive for all nasal passage and bronchoalveolar lavage (BAL) specimens. Histopathologic scores ranged from 0 to 21. The mean log 10 (cfu/mL) were 4.1-6.4 on days 1-10 and ≥1.7 on days 13-15 for nasal passage and BAL specimens. Serum polymerase chain reaction was negative. ELISA for serum IgM and immunoblots for M. pneumoniae antibody were positive in 21 (62%) of 34 and 33 (97%) of 34 infected animals, respectively, at days 8-15. ELISA for IgG antibody was negative. This mouse pneumonia model can be used to study the immunologic and therapeutic responses to acute M. pneumoniae infection.
stituted in SP4 broth [3] and subcultured after 24-48 h in a culture flask containing 20 mL of SP4 media. The flask was incubated at 37ЊC, and 72 h later the supernatant was decanted. Two milliliters of fresh SP4 broth was added; a cell scraper was used to remove M. pneumoniae from the sides of the flask. Aliquots were stored at Ϫ70ЊC.
Animals. Female Mycoplasma-and murine virus-free BALB/ c mice (ages 7-11 weeks and weighing 18-20 g) were used. Their virus-free status was confirmed by use of sentinel mice at Charles River Breeding Laboratories (Wilmington, MA). Mice were housed in filter-top cages and allowed to acclimate to the new environment for 1 week.
Sedation for inoculation. Metofane (Pitman-Moore, Mundelein, IL), a nonflammable, inhaled anesthetic, was used for sedation. To determine the effect of metofane on M. pneumoniae, 1 mL of M. pneumoniae ATCC 29342 was exposed in a closed jar to metofane vapors. A control dish of the organism was placed in room air. Twenty-five microliters was removed from each dish at 30-s intervals for 5 min and then every 5 min for a total of 15 min. Samples were placed on SP4 agar and incubated at 37ЊC, and colonies were counted on days 5-7.
Inoculation. Inoculation was done on days 0, 1, and 2 in control and infected mice. In the latter, 50 mL of broth containing cfu/mL M. pneumoniae was delivered intranasally by mi- 6 5 ϫ 10 cropipette, and each mouse was held upright for 15 s. Control animals were inoculated with sterile broth. Sample collection. An intraperitoneal injection of 75 mg/kg ketamine and 5 mg/kg acepromazine provided sedation before cardiac puncture. The anterior chest wall and mandible were removed exposing the sinuses, trachea, and lungs. Individual blood, nasal passage, bronchoalveolar lavage, and lung specimens were collected from 5-10 mice on days 0, 1, 2, 4, 6, 8, 10, 13, and 15 as described below.
Cardiac puncture. Whole blood was obtained via cardiac puncture and centrifuged at 3500 g for 10 min. The serum was stored at Ϫ70ЊC.
BAL. A 25-gauge needle was inserted between the tracheal rings, and a Dieffenbach Serrefine forceps was placed on the hub of the needle. After a 1-mL tuberculin syringe was filled, 0.3 mL of SP4 culture broth was washed in and out of the bronchial tree 3-5 times, and 100 mL of the fluid was immediately processed for culture; the rest was stored at Ϫ70ЊC. Nasal passage lavage. The proximal end of the trachea was removed revealing a small opening to the nasal passages. A 25-gauge needle was inserted into the nasal passage opening, and 0.3 mL of SP4 culture broth was flushed in and out 3-5 times. In total, 100 mL of fluid was processed for culture; the rest was stored at Ϫ70ЊC.
Fixation of the lungs. A 10% formalin solution (2 mL) was instilled into the bronchial tree, and the trachea, lungs, and heart were placed in formalin.
Sample cultures. We diluted 100 mL of BAL and sinus wash samples 10-fold to 10 Ϫ4 in SP4 broth. After 24 h, 25 mL of each dilution was plated on SP4 agar plates and incubated at 37ЊC.
Reading and interpretation. Broth cultures usually turned orange on days 3-6, indicating growth of Mycoplasma organisms. Aliquots were stored at Ϫ70ЊC. Random samples from positive broth cultures were evaluated by PCR in the laboratory of one of us (G.C.) using 16S primers to confirm the presence of M. pneumoniae by the method of Williamson et al. [4] . Agar plates were monitored weekly, and organisms were enumerated using a dissecting microscope. The broth and agar plates were considered negative if there was no growth after 6 weeks of incubation.
Serum PCR. Random samples of serum were evaluated by PCR in our laboratory using open-reading frame 6 primers to M. pneumoniae (Abbott Diagnostics, Abbott Park, IL) [5] .
Histopathology. A histologic scoring system adapted from a hamster M. pneumoniae pneumonia model was applied to our model [6] . Lung specimens were evaluated for the percentage of involved sites with peribronchiolar and bronchial infiltrates, quality of infiltrates, luminal exudates, perivascular infiltrates, and parenchymal pneumonia.
Immunologic studies. IgM and IgG antibodies to M. pneumoniae were determined in mice as described previously for detection of Mycoplasma pulmonis antibodies in mice, except that 1% bovine serum albumin-PBS was used to block the plates and dilute the samples [7] [8] [9] . The M. pneumoniae antigen was prepared as described for ELISA for detection of antibodies in humans [10, 11] . A sample was considered weakly positive if its optical density (OD) reading was ≥2 SD above the mean value of the control serum samples and strongly positive if the OD reading was ≥3 SD above the mean value of normal serum.
Immunoblotting of sera (diluted 1:100) for detection of M. pneumoniae antibodies was done using methods previously described [12, 13] . Hyperimmune rabbit sera and human sera previously shown to be IgM-and IgG-positive by ELISA were used for comparison as was serum from normal control mice. A sample was considered to be immunoblot-positive if it was reactive with proteins of 29.6, 52.2, 87.5, or 131.4 kDa. These represent proteins that are specific for M. pneumoniae.
Results
Clinical findings. The animals showed no respiratory signs of pneumonia; however, their hair appeared ragged on days 3 and 4 and returned to healthy condition by day 8.
M. pneumoniae and metofane exposure. Exposure to metofane vapors did not result in significant reduction of numbers of M. pneumoniae recovered by culture.
Serum PCR. Twenty serum samples selected from mice with the highest colony counts in BAL on days 4, 6, 8, 10, 13, and 15 were evaluated by PCR. A positive result was defined as 1500 absorbance units. The mean absorbance for all samples was 43 (range, 34-71).
Bronchoalveolar lavage. Broth cultures were positive in all infected mouse specimens collected from days 0 to 15 of the experiments and negative in all control mice. All 8 randomly selected BAL specimens were PCR-positive for M. pneumoniae. The mean Mycoplasma titers (log 10 cfu/mL) on days 0, 1, 2, 4, 6, 8, 10, 13, and 15 were 6.8, 6.0, 6.3, 6.4, 5.6, 5.4, 4.1, 1.7, and 1.7, respectively (figure 1).
Nasal passage wash. Broth cultures of nasal passage washes were positive in all infected mouse specimens and negative in all control animals. Five randomly selected wash specimens were PCR-positive for M. pneumoniae. The mean titers on days 0, 1, 2, 4, 6, 8, 10, 13, and 15 were 5.5, 4.2, 5.2, 5.5, 5.1, 5.3, 3.6, 3.1, and 2.4 log 10 cfu/mL, respectively.
Histopathology. This experiment was performed in duplicate, and 76 animals were combined from days 0 to 15. On day 0, all lung specimens had normal histology. There were 68 mice in total for days 1-15. An inflammatory response was demonstrated on day 1 after inoculation and persisted throughout the experiment. Peribronchiolar, bronchial, and perivascular infiltrates and luminal occlusion and parenchymal pneumonia were present. The greatest inflammatory response was observed on days 1-4 (histopathology scores, 5-21). The heaviest confluent parenchymal infiltrates occurred on day 4 (figure 1). The mean histopathology score on days 0, 1, 2, 4, 6, 8, 13, and 15 was 0, 11, 12, 14, 9, 8, 4, and 6, respectively.
Immunoglobulin and immunoblot studies. For all healthy control and infected mice, the mean OD IgG readings were !0.002 and !0.005, respectively. The mean OD IgM reading for control mice was 0.065 (0.015 SD). In contrast, the mean IgM value for infected mice increased progressively from an OD of 0.069 on day 0 to 0.131 on day 15 of the experiments. Twentyone (62%) of 34 and 17 of 34 IgM antibody values were 2 and 3 SD, respectively, higher than IgM values for control mice at or after day 8. Immunoblots for M. pneumoniae antibody were positive in 33 (97%) of 34 animals, including immunoblots for 13 mice that were negative by ELISA at or after day 8. All immunoblots were negative at !6 days of infection.
Control animals. Control mice were sacrificed on days 0 (1 mouse), 1 (1), 2 (2), 5 (2), 11 (2) , and 15 (2). All controls had negative BAL and nasal passage cultures, immunoblot, and IgG and IgM antibodies for M. pneumoniae and histopathologic scores of 0 or 1.
Discussion
This mouse M. pneumoniae pneumonia model provides new opportunities for analyzing the molecular pathophysiology and course of acute infection by this organism in vivo. The model uses a human M. pneumoniae pathogen to produce pneumonia in the mouse as demonstrated by histologic and immunologic techniques. Three consecutive days of intranasal inoculation induced disease in infected animals but not in control mice. We made multiple inoculations because we found that a single inoculum with ATCC 15331 in mice produced colonization only without histopathologic changes (data not shown).
Sedation for inoculation of organisms is critical. Metofane is an inhaled anesthetic agent approved by the Food and Drug Administration for use in animals. It requires minimal precautions and produces rapid sedation, and because respirations remain at normal levels during intranasal inoculation, organisms are evenly distributed throughout the bronchial tree. Exposure of M. pneumoniae to vaporized metofane did not inhibit growth of the organism.
We tested mouse serum samples by PCR because others have used the procedure as a marker for disease [14] . In that study, mycoplasmal bacteremia in children with pneumonia was rarely detected by PCR but was frequently positive with Mycoplasma central nervous system disease in the absence of pneumonia. The data from our model suggest that serum PCR is not a reliable indicator of pneumonia in the mouse.
This animal model uses the same mouse to compare all samples. The histologic scoring system used was chosen because it provides a reproducible system to identify small differences in the pulmonary inflammatory response. In this model, control animals did not have an inflammatory response, but infected animals had extensive bronchopneumonia.
The final step in this animal model was to demonstrate that disease caused by Mycoplasma organisms was associated with an immunologic response in the early phase of infection. Although there are no standardized assays in the mouse using ELISA and immunoblot for detection of M. pneumoniae antibodies, we formulated baseline immunologic data based on ELISA values from humans and from the M. pulmonis mouse pneumonia model [7, 10] . Both ELISA and immunoblot were performed, since discordance in results can occur if some epitopes are destroyed during the denaturing steps, and some nonprotein antigens can be missed. All positive IgM ELISA samples were ≥2 SD above the control mouse values. Twentyfive (75%) of 33 positive immunoblots obtained at or after day 8 correlated with an ELISA IgM ≥1 SD above the mean control mouse values. Although the disease was mild and the clinical course short, future detailed studies evaluating the later phases of infection will help better define the immunologic response to M. pneumoniae in the mouse pneumonia model.
